Merging lithium carbenoid homologation and enzymatic reduction: A combinative approach to the HIV-protease inhibitor Nelfinavir

被引：22

作者：

Castoldi, Laura ^{[1
]}

Ielo, Laura ^{[1
,2
]}

Hoyos, Pilar ^{[3
]}

Hernaiz, Maria J. ^{[3
]}

De Luca, Laura ^{[2
]}

Alcantara, Andres R. ^{[3
]}

Holzer, Wolfgang ^{[1
]}

Pace, Vittorio ^{[1
]}

机构：

[1] Univ Vienna, Dept Pharmaceut Chem, Althanstr 14, A-1090 Vienna, Austria

[2] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Annunziata, I-98168 Messina, Italy

[3] Univ Complutense Madrid, Dept Chem Pharmaceut Sci QUIMCIFARM, Pza Ramon y Cajal S-N, Madrid 28040, Spain

来源：

TETRAHEDRON | 2018年 / 74卷 / 18期

关键词：

Homologation; Lithium carbenoids; Enzymatic reductions; Drug Synthesis; a-haloketones; Halohydrins; Selectivity; ALPHA'-CHLOROMETHYLKETONE DERIVATIVES; CONTINUOUS-FLOW SYNTHESIS; CYCLOPENTYL METHYL-ETHER; WEINREB AMIDES; ORGANIC-SYNTHESIS; ORGANOMETALLIC CHEMISTRY; CHEMOSELECTIVE ADDITION; DIAZOCARBONYL COMPOUNDS; ANHYDROUS DIAZOMETHANE; STRAIGHTFORWARD ACCESS;

D O I：

10.1016/j.tet.2018.03.034

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

An effective stereocontrolled synthesis of the HIV protease inhibitor Nelfinavir is reported. Two transformations were identified crucial for achieving success: the formation of a densely functionalized alpha-chloroketone via the homologation of a Weinreb amide with chloromethyllithium (LiCH2Cl), followed by its erythro selective reduction into the corresponding chiral chlorohydrin. A commercially available enzyme P2-CO2 was particularly well suited for this purpose, affording the key alcohol (in an excellent 99% de), which was then smoothly converted into the active biologically active agent. Published by Elsevier Ltd.

引用

页码：2211 / 2217

页数：7

共 90 条

[21] Stability and reactivity control of carbenoids: recent advances and perspectives [J].

Gessner, Viktoria H. .

CHEMICAL COMMUNICATIONS, 2016, 52 (81) :12011-12023

[22]

Gohring W, 1996, CHIMIA, V50, P532

[23] Asymmetric transfer hydrogenation of α-aminoalkyl α′-chloromethyl ketones with chiral Rh complexes [J].

Hamada, T ;

Torii, T ;

Onishi, T ;

Izawa, K ;

Ikariya, T .

JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (21) :7391-7394

[24] New approaches to the industrial synthesis of HIV protease inhibitors [J].

Honda, Y ;

Katayama, S ;

Kojima, M ;

Suzuki, T ;

Kishibata, N ;

Izawa, K .

ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (14) :2061-2070

[25] Synthesis of a Long Acting HIV Protease Inhibitor via Metal or Enzymatic Reduction of the Appropriate Chloro Ketone and Selective Zinc Enolate Condensation with an Amino Epoxide [J].

Houpis, Ioannis N. ;

Liu, Renmao ;

Liu, Lin ;

Wang, Yanfei ;

Dong, Nengfa ;

Zhao, Xiangan ;

Zhang, Yan ;

Xiao, Tingting ;

Wang, Youchu ;

Depre, Dominique ;

Nettekoven, Ulrike ;

Vogel, Michael ;

Wilson, Rob ;

Collier, Steve .

ADVANCED SYNTHESIS & CATALYSIS, 2013, 355 (09) :1829-1839

[26]

Ikunaka M, 2002, ORG PROCESS RES DEV, V6

[27] (1S)-1-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2-hydroxyethylammonium benzoate, a versatile building block for chiral 2-aminoalkanols:: Concise synthesis and application to nelfinavir, a potent HIV-protease inhibitor [J].

Inaba, T ;

Yamada, Y ;

Abe, H ;

Sagawa, S ;

Cho, H .

JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (06) :1623-1628

[28] Industrial syntheses of the central core molecules of HIV protease inhibitors [J].

Izawa, Kunisuke ;

Onishi, Tomoyuki .

CHEMICAL REVIEWS, 2006, 106 (07) :2811-2827

[29] A SYSTEMATIC STUDY OF P-1-P-3 SPANNING SIDE-CHAINS FOR THE INHIBITION OF HIV-1 PROTEASE [J].

KALDOR, SW ;

APPELT, K ;

FRITZ, JE ;

HAMMOND, M ;

CROWELL, TA ;

BAXTER, AJ ;

HATCH, SD ;

WISKERCHEN, M ;

MUESING, MA .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (07) :715-720

[30] Viracept (nelfinavir mesylate, AG1343): A potent, orally bioavailable inhibitor of HIV-1 protease [J].

Kaldor, SW ;

Kalish, VJ ;

Davies, JF ;

Shetty, BV ;

Fritz, JE ;

Appelt, K ;

Burgess, JA ;

Campanale, KM ;

Chirgadze, NY ;

Clawson, DK ;

Dressman, BA ;

Hatch, SD ;

Khalil, DA ;

Kosa, MB ;

Lubbehusen, PP ;

Muesing, MA ;

Patick, AK ;

Reich, SH ;

Su, KS ;

Tatlock, JH .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (24) :3979-3985

← 1 2 3 4 5 6 7 8 9 →